Only two antibiotics defined by the WHO as innovative have been approved in the last few years
Status in early 2024 of innovative antibiotics (as defined* by the WHO) reported in development between 2017 and 2021.
WHO defines innovative by four criteria: a new chemical class, new target, new mode of action, and/or no cross-resistance to other antibiotic classes
